Rectal diclofenac versus high-dose rectal acetaminophen in children: A randomized clinical trial

Houman Hashemian1, Marzie Fallah Khodadoost1

  • 1Pediatric Diseases Research Center , Guilan University of Medical Sciences, Rasht, Iran.

Insights

Diclofenac suppositories were more effective than high-dose acetaminophen suppositories in reducing fever in children aged 1-6 years. Both medications significantly lowered temperature, but diclofenac showed a greater reduction in pediatric fever.

Area of Science:

  • Pediatrics
  • Pharmacology
  • Clinical Medicine

Background:

  • Fever is a prevalent symptom in children admitted to healthcare facilities.
  • This study addresses the common clinical challenge of managing pediatric fever.

Purpose of the Study:

  • To compare the antipyretic efficacy of diclofenac and high-dose acetaminophen suppositories.
  • To evaluate fever reduction in children aged 1 to 6 years.

Main Methods:

  • A double-blind clinical trial involving 90 children (1-6 years old).
  • Participants received either high-dose acetaminophen (30 mg/kg) or diclofenac (1 mg/kg) suppositories.
  • Rectal temperature was measured at baseline, 1 hour, and 3 hours post-administration.

Main Results:

  • Diclofenac group showed a significantly greater temperature reduction (1.76±0.95°C) compared to the acetaminophen group (1.26±0.49°C).
  • The difference in temperature reduction between the two groups was statistically significant (P=0.019).

Conclusions:

  • Both acetaminophen and diclofenac suppositories effectively reduce fever in children.
  • Rectal diclofenac demonstrates a superior antipyretic effect compared to rectal acetaminophen in this pediatric population.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
58
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
71
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
49
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
35